|
|
|
Insider
Information: |
Kaneko Yasunori |
Relationship: |
10% Owner |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
1,448,130 |
|
Indirect Shares
|
13,305,532 |
|
|
Direct
Value |
$4,061,523 |
|
|
Indirect Value
|
$99,923,529 |
|
|
Total
Shares |
14,753,662 |
|
|
Total
Value |
$103,985,052 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
3.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Renovis Inc |
RNVS |
Director |
|
0 |
2004-02-10 |
198,412 |
Premium* |
|
Xenoport Inc |
XNPT |
N/A |
2005-06-07 |
0 |
2005-06-07 |
22,533 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
former 10% holder |
2014-02-04 |
0 |
2015-02-20 |
1,719,671 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
10% Owner |
|
0 |
2014-02-20 |
1,208,920 |
Premium* |
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
2014-03-07 |
0 |
2014-03-07 |
2,871,933 |
Premium* |
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2014-10-27 |
1,432,930 |
2014-10-27 |
0 |
Premium* |
|
Collegium Pharmaceutical, Inc |
COLL |
10% Owner |
2015-05-12 |
0 |
2017-12-05 |
270 |
Premium* |
|
Arcus Biosciences Inc |
RCUS |
Director |
2024-06-06 |
15,200 |
2024-06-06 |
903,755 |
Premium* |
|
Sutro Biopharma Inc |
STRO |
10% Owner |
2018-10-01 |
0 |
2018-10-01 |
1,960,053 |
Premium* |
|
Si-Bone, Inc. |
SIBN |
10% Owner |
2018-10-19 |
0 |
2018-10-19 |
4,419,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TARA |
Protara Therapeutics, Inc |
10% Owner |
|
2014-10-27 |
4 |
B |
$10.00 |
$2,000,000 |
D/D |
200,000 |
200,000 |
2.45 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
10% Owner |
|
2014-02-20 |
4 |
B |
$14.00 |
$2,100,000 |
I/I |
150,000 |
1,208,920 |
1.5 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
10% Owner |
|
2014-02-04 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
1,734,751 |
1.5 |
- |
|
SIBN |
Si-Bone, Inc. |
10% Owner |
|
2018-10-19 |
4 |
B |
$15.00 |
$4,875,000 |
I/I |
325,000 |
4,419,985 |
1.5 |
- |
|
29 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|